Deerfield Management as of March 31, 2015
Portfolio Holdings for Deerfield Management
Deerfield Management holds 122 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Auspex Pharmaceuticals | 14.4 | $446M | 4.4M | 100.27 | |
| Horizon Pharma | 10.8 | $332M | 13M | 25.97 | |
| Allscripts Healthcare So conv | 3.2 | $99M | 101M | 0.98 | |
| Abbvie (ABBV) | 2.9 | $90M | 1.5M | 58.54 | |
| NxStage Medical | 2.8 | $88M | 5.1M | 17.30 | |
| Array BioPharma | 2.8 | $87M | 12M | 7.37 | |
| Avalanche Biotechnologies In | 2.8 | $86M | 2.1M | 40.52 | |
| Horizon Pharma Inc note 5.000%11/1 | 2.5 | $78M | 16M | 4.88 | |
| Bluebird Bio (BLUE) | 2.5 | $76M | 631k | 120.77 | |
| Flamel Technologies | 2.4 | $73M | 4.1M | 17.98 | |
| DaVita (DVA) | 1.9 | $59M | 730k | 81.28 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.8 | $56M | 45M | 1.25 | |
| Infinity Pharmaceuticals (INFIQ) | 1.8 | $56M | 4.0M | 13.98 | |
| Universal American | 1.8 | $55M | 5.2M | 10.68 | |
| Integra Lifesciences Holdings conv bnd | 1.8 | $55M | 47M | 1.15 | |
| Spark Therapeutics | 1.6 | $49M | 631k | 77.50 | |
| Walgreen Boots Alliance (WBA) | 1.4 | $43M | 513k | 84.68 | |
| Zafgen | 1.4 | $42M | 1.1M | 39.61 | |
| GlaxoSmithKline | 1.3 | $40M | 873k | 46.15 | |
| Arena Pharmaceuticals | 1.3 | $40M | 9.2M | 4.37 | |
| Endologix | 1.3 | $40M | 2.3M | 17.07 | |
| Vanda Pharmaceuticals (VNDA) | 1.2 | $38M | 4.1M | 9.30 | |
| Endologix Inc note 2.250%12/1 | 1.1 | $35M | 35M | 1.01 | |
| Insmed (INSM) | 1.1 | $34M | 1.6M | 20.80 | |
| Gw Pharmaceuticals Plc ads | 1.1 | $33M | 364k | 91.13 | |
| Antares Pharma | 1.1 | $33M | 12M | 2.71 | |
| eHealth (EHTH) | 1.0 | $31M | 3.3M | 9.38 | |
| Aetna | 1.0 | $30M | 284k | 106.53 | |
| Sage Therapeutics (SAGE) | 1.0 | $30M | 595k | 50.23 | |
| Xencor (XNCR) | 0.9 | $29M | 1.9M | 15.32 | |
| Achillion Pharmaceuticals | 0.9 | $28M | 2.8M | 9.86 | |
| Accuray Inc Del note 3.750% 8/0 | 0.9 | $27M | 24M | 1.11 | |
| Webmd Health Corp 1.5% cnvrtbnd | 0.8 | $24M | 23M | 1.06 | |
| Heartware Intl Inc note 3.500%12/1 | 0.8 | $23M | 21M | 1.14 | |
| Charles River Laboratories (CRL) | 0.7 | $23M | 290k | 79.29 | |
| Orthofix International Nv Com Stk | 0.7 | $23M | 630k | 35.89 | |
| Alimera Sciences | 0.7 | $22M | 4.4M | 5.01 | |
| Portola Pharmaceuticals | 0.7 | $22M | 575k | 37.96 | |
| McKesson Corporation (MCK) | 0.7 | $21M | 92k | 226.20 | |
| Gilead Sciences (GILD) | 0.6 | $20M | 200k | 98.13 | |
| Loxo Oncology | 0.6 | $20M | 1.6M | 12.45 | |
| Aerie Pharmaceuticals | 0.6 | $19M | 606k | 31.34 | |
| Inogen (INGN) | 0.6 | $19M | 602k | 31.99 | |
| Humana (HUM) | 0.6 | $19M | 106k | 178.02 | |
| Dyax | 0.6 | $19M | 1.1M | 16.76 | |
| Pacific Biosciences of California (PACB) | 0.6 | $18M | 3.0M | 5.84 | |
| Trupanion (TRUP) | 0.5 | $17M | 2.1M | 8.00 | |
| NuVasive | 0.5 | $16M | 338k | 45.99 | |
| Anthem (ELV) | 0.5 | $15M | 100k | 154.41 | |
| Nanostring Technologies (NSTGQ) | 0.5 | $15M | 1.5M | 10.19 | |
| Proteon Therapeutics | 0.5 | $15M | 1.3M | 11.63 | |
| Imprivata | 0.5 | $14M | 1.0M | 14.00 | |
| Ovascience | 0.5 | $14M | 407k | 34.73 | |
| Axogen (AXGN) | 0.4 | $14M | 3.9M | 3.50 | |
| Therapeuticsmd | 0.4 | $14M | 2.2M | 6.05 | |
| Aac Holdings | 0.4 | $14M | 446k | 30.58 | |
| Immunomedics | 0.4 | $12M | 3.0M | 3.83 | |
| Juno Therapeutics | 0.4 | $11M | 183k | 60.66 | |
| Steadymed | 0.3 | $11M | 1.3M | 8.50 | |
| Fluidigm Corporation convertible cor | 0.3 | $11M | 10M | 1.06 | |
| Trivascular Technologies | 0.3 | $10M | 990k | 10.49 | |
| Exelixis (EXEL) | 0.3 | $10M | 4.0M | 2.57 | |
| Genesis Healthcare Inc Cl A (GENN) | 0.3 | $10M | 1.4M | 7.12 | |
| Keryx Biopharmaceuticals | 0.3 | $9.7M | 766k | 12.73 | |
| Genocea Biosciences | 0.3 | $10M | 844k | 11.86 | |
| Adeptus Health Inc-class A | 0.3 | $10M | 199k | 50.22 | |
| Rigel Pharmaceuticals (RIGL) | 0.3 | $8.6M | 2.4M | 3.57 | |
| Tonix Pharmaceuticls | 0.3 | $8.6M | 1.4M | 6.32 | |
| Derma Sciences | 0.3 | $8.4M | 991k | 8.47 | |
| Alcobra | 0.3 | $8.0M | 1.4M | 5.63 | |
| Syneron Medical Ltd ord | 0.2 | $7.7M | 626k | 12.38 | |
| Healthways Inc note 1.500% 7/0 | 0.2 | $7.8M | 6.7M | 1.17 | |
| Oxford Immunotec Global | 0.2 | $7.4M | 522k | 14.08 | |
| Alphatec Holdings | 0.2 | $7.2M | 5.0M | 1.45 | |
| Dbv Technologies S A (DBVT) | 0.2 | $7.0M | 298k | 23.36 | |
| Amphastar Pharmaceuticals (AMPH) | 0.2 | $6.7M | 449k | 14.96 | |
| Tracon Pharmaceuticals | 0.2 | $6.8M | 485k | 14.04 | |
| Streamline Health Solutions (STRM) | 0.2 | $6.5M | 1.8M | 3.55 | |
| Versartis | 0.2 | $6.2M | 340k | 18.37 | |
| Zs Pharma | 0.2 | $6.2M | 147k | 42.08 | |
| Foamix Pharmaceuticals | 0.2 | $6.3M | 680k | 9.25 | |
| Biotelemetry | 0.2 | $5.7M | 644k | 8.85 | |
| Lumenis Ltd shs cl b | 0.2 | $5.2M | 435k | 11.97 | |
| Cellectis S A (CLLS) | 0.2 | $5.2M | 151k | 34.58 | |
| Cara Therapeutics (CARA) | 0.1 | $4.8M | 474k | 10.05 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $4.6M | 209k | 21.88 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $4.6M | 226k | 20.23 | |
| Cross Country Healthcare (CCRN) | 0.1 | $4.3M | 367k | 11.86 | |
| CAS Medical Systems | 0.1 | $4.3M | 3.2M | 1.34 | |
| Discovery Laboratories | 0.1 | $4.4M | 3.7M | 1.19 | |
| Caredx (CDNA) | 0.1 | $4.5M | 804k | 5.54 | |
| Scynexis | 0.1 | $4.1M | 493k | 8.30 | |
| Exelixis Inc cnv | 0.1 | $3.7M | 5.0M | 0.75 | |
| Retrophin | 0.1 | $3.8M | 158k | 23.96 | |
| Dermira | 0.1 | $3.6M | 232k | 15.35 | |
| St. Jude Medical | 0.1 | $3.3M | 50k | 65.40 | |
| Sucampo Pharmaceuticals | 0.1 | $3.5M | 225k | 15.56 | |
| Ascendis Pharma A S (ASND) | 0.1 | $3.5M | 200k | 17.35 | |
| Invitae (NVTAQ) | 0.1 | $2.8M | 167k | 16.76 | |
| Palatin Technologies | 0.1 | $2.0M | 2.0M | 1.02 | |
| Kindred Biosciences | 0.1 | $2.0M | 279k | 7.14 | |
| Bovie Medical Corporation | 0.1 | $1.7M | 700k | 2.39 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $1.6M | 49k | 32.59 | |
| Mei Pharma | 0.1 | $1.4M | 803k | 1.79 | |
| Illumina (ILMN) | 0.0 | $1.2M | 6.4k | 185.62 | |
| Parnell Pharmaceuticals Holdin (PARNF) | 0.0 | $1.2M | 254k | 4.91 | |
| Plasmatech Biopharmaceutical | 0.0 | $1.1M | 350k | 3.14 | |
| Alkermes (ALKS) | 0.0 | $1.1M | 18k | 60.97 | |
| Mirati Therapeutics | 0.0 | $965k | 33k | 29.32 | |
| Agile Therapeutics | 0.0 | $973k | 105k | 9.27 | |
| Abbott Laboratories (ABT) | 0.0 | $602k | 13k | 46.31 | |
| Nektar Therapeutics (NKTR) | 0.0 | $502k | 46k | 11.01 | |
| Aeterna Zentaris | 0.0 | $485k | 899k | 0.54 | |
| Mazor Robotics Ltd. equities | 0.0 | $470k | 42k | 11.23 | |
| Mylan Nv | 0.0 | $594k | 10k | 59.40 | |
| Rite Aid Corporation | 0.0 | $459k | 53k | 8.70 | |
| Celgene Corporation | 0.0 | $403k | 3.5k | 115.14 | |
| HMS Holdings | 0.0 | $462k | 30k | 15.45 | |
| Oncothyreon | 0.0 | $233k | 143k | 1.63 | |
| Esperion Therapeutics (ESPR) | 0.0 | $232k | 2.5k | 92.80 | |
| Plasmatech Biopharmaceutical *w exp 10/24/201 | 0.0 | $319k | 375k | 0.85 | |
| Imris (IMRSQ) | 0.0 | $141k | 147k | 0.96 |
